University of Zurich / Universität Zürich (UZH)

University / College


Location: Zürich, Switzerland (CH) CH

ISNI: 0000000419370650

ROR: https://ror.org/02crff812

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A large-scale functional high-throughput screening identifies miR-515 and miR-519e as potent inducers of human iPSC-cardiomyocyte proliferation (2022) Renikunta HV, Lazarow K, Gong Y, Shukla PC, Giral H, Kratzer A, Nageswaran V, et al. Conference contribution Using Copper-Doped Mesoporous Bioactive Glass Nanospheres to Impart Anti-Bacterial Properties to Dental Composites (2022) Munir A, Marovic D, Nogueira LP, Simm R, Naemi AO, Landro SM, Helgerud M, et al. Journal article Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy (2022) Buettner FA, Winter S, Stuehler V, Rausch S, Hennenlotter J, Füssel S, Zastrow S, et al. Journal article What is walking? a systematic review and meta-ethnography (2022) Delgado Ortiz L, Polhemus A, Keogh A, Sutton N, Remmele W, Hansen C, Kluge F, et al. Conference contribution Embryonic and neonatal waves generate distinct populations of hepatic ILC1s (2022) Sparano C, Solís-Sayago D, Vijaykumar A, Rickenbach C, Vermeer M, Ingelfinger F, Litscher G, et al. Journal article Unique characteristics of AQP4-specific T cells in patients with AQP4+neuromyelitis optica spectrum disorder (NMOSD) (2022) Saggau C, Bacher P, Esser D, Leypoldt F, Wandinger KP, Paul F, Martin R, et al. Conference contribution Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks (2022) Ruhl L, Pink I, Kuehne JF, Beushausen K, Keil J, Christoph S, Sauer A, et al. Conference contribution Short-term Safety of COVID-19 Vaccination in Systemic Sclerosis Patients: Report from a Global Patient-Reported E-survey (2022) Thakare D, Naveen R, Pauling J, Ahmed S, Wincup C, Del Papa N, Sambataro G, et al. Conference contribution Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey (2022) Ahmed S, Naveen R, Pauling J, Thakare D, Wincup C, Del Papa N, Sambataro G, et al. Conference contribution